It has come to the attention of the authors that Table 5 was not included in *Epigenetics* Volume 7, Issue 3 in the manuscript: Lepeule J, Baccarelli A, Tarantini L, Motta V, Cantone L, Litonjua AA, et al. Gene promoter methylation is associated with lung function in the elderly: The normative aging study. Epigenetics 2012; 7:261-9.

Table 5 for this manuscript is published here:

The citation for Table 5 should have appeared on p. 264, "**Sensitivity analyses.** The sensitivity analyses including par-ticipants with chronic lung diseases showed similar associations between lung function and DNA methylation as the main analy-ses, with only slight variations in significance (Table 5)."

###### Percent change in lung function associated\* with an interquartile range decrease in gene-specific DNA methylation (percentage of 5-methylcytosine), in 756 men participating to the Normative Aging Study, Boston, 1999-2006

  Gene   n obs./n subjects   FVC         FEV~1~         FEV~1~/FVC^†^   MMEF                                             
  ------ ------------------- ----------- -------------- --------------- -------------- ---------- ---------- ----------- --------------
  CRAT   949/599             **-1.70**   **0.02**       **-2.28**       **\<10^-2^**   -0.43      0.09       -1.74       0.24
  F3     895/583             **-2.61**   **\<10^-4^**   **-2.02**       **\<10^-2^**   0.39       0.07       1.35        0.28
  GCR    853/550             -1.00       0.08           -1.07           0.09           -0.05      0.82       -0.72       0.54
  ICAM   772/522             0.63        0.35           **1.57**        **0.05**       **0.65**   **0.01**   **4.56**    **\<10^-2^**
  IFNg   983/611             1.01        0.14           1.37            0.07           0.28       0.25       **3.05**    **0.03**
  IL6    992/607             **1.51**    **0.03**       **2.26**        **\<10^-2^**   **0.49**   **0.05**   **3.42**    **0.02**
  iNOS   648/456             -1.63       0.06           -1.75           0.07           -0.07      0.83       -0.41       0.83
  OGG1   629/450             -1.03       0.13           -1.17           0.14           -0.04      0.88       -0.08       0.96
  TLR2   828/538             **-2.03**   **\<10^-3^**   **-2.31**       **\<10^-3^**   -0.22      0.32       **-3.47**   **\<10^-2^**

Results were adjusted for age (continuous), race (white/black), log (height), standardized weight (linear and quadratic term), % neutrophils, % leucocytes, education level (\<12, 12, 13-15, \>15 y), smoking status (former/current/never), cumulative smoking (continuous), season of the medical exam (indicator variable), day of the week, corticosteroids (Y/N), sympathomimetic alpha and beta (Y/N), anticholinergics (Y/N), methacholine challenge test (Y/N), asthma (Y/N), chronic bronchitis (Y/N), emphysema (Y/N). ^†^Absolute change in FEV1/FVC.
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